European Cancer Summit 2024
GLIOMATCH was featured at the European Cancer Summit 2024, held on 20–21 November in Brussels and online. We’re proud to support Europe’s fight against cancer.
THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
Adult glioblastoma
Paediatric high-grade glioma
EU initiative for understanding cancer
Magnetic resonance imaging
Standard of care
Immuno-oncology
Tumour treating fields
GLIOMATCH was featured at the European Cancer Summit 2024, held on 20–21 November in Brussels and online. We’re proud to support Europe’s fight against cancer.
GLIOMATCH project coordinator, Prof Frederik de Smet, held a lecture about how immunotherapy can be harnessed for brain cancer research.
Glioblastoma Awareness Day (GBM Day) on 17 July 2024 aimed to raise awareness and support for those affected by glioblastoma, an aggressive brain tumour. GLIOMATCH’s month-long campaign is summarised in this article, highlighting the critical need for further research.